Cargando…

Monocyte matrix metalloproteinase production in Type 2 diabetes and controls – a cross sectional study

BACKGROUND: Coronary plaque rupture may result from localised over expression of matrix metalloproteinases (MMPs) within the plaque by infiltrating monocyte – macrophages. As MMP expression can be promoted by the modified lipoproteins, oxidative stress and hyperglycaemia that characterises Type 2 di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baugh, Mark D, Gavrilovic, Jelena, Davies, Isabel R, Hughes, David A, Sampson, Mike J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC152657/ https://www.ncbi.nlm.nih.gov/pubmed/12672267 http://dx.doi.org/10.1186/1475-2840-2-3

Ejemplares similares

Low density lipoprotein from patients with Type 2 diabetes increases expression of monocyte matrix metalloproteinase and ADAM metalloproteinase genes
por: Worley, Joanna R, et al.
Publicado: (2007)

Plasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetes
por: Sampson, Mike, et al.
Publicado: (2004)

Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis
por: Kumar, Nathella P., et al.
Publicado: (2020)

Expression of CD147 on monocytes/macrophages in rheumatoid arthritis: its potential role in monocyte accumulation and matrix metalloproteinase production
por: Zhu, Ping, et al.
Publicado: (2005)

Modulation of monocyte matrix metalloproteinase-2 by breast adenocarcinoma cells
por: Szabo, Kristina A, et al.
Publicado: (2005)

Pro-oxidant effect of α-tocopherol in patients with Type 2 Diabetes after an oral glucose tolerance test – a randomised controlled trial
por: Winterbone, Mark S, et al.
Publicado: (2007)

Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
por: Peeters, Stijn A, et al.
Publicado: (2015)

Matrix Metalloproteinase 9 Production by Monocytes is Enhanced by TNF and Participates in the Pathology of Human Cutaneous Leishmaniasis
por: Campos, Taís M., et al.
Publicado: (2014)

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies
por: Peeters, Stijn A., et al.
Publicado: (2017)

Evaluation of serum neopterin, periostin, Tenascin‐C, tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-2 levels in obese pregnant women
por: Melekoğlu, Rauf, et al.
Publicado: (2022)

Evaluation of matrix metalloproteinase type IV-collagenases in serum of patients with tumors of the central nervous system
por: Ricci, Serena, et al.
Publicado: (2016)

Impact of CD14(++)CD16(+) monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study
por: Yoshida, Naofumi, et al.
Publicado: (2017)

Matrix Metalloproteinases in Diabetic Kidney Disease
por: Garcia-Fernandez, Nuria, et al.
Publicado: (2020)

Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast Carcinomas
por: Iwata, Hiroji, et al.
Publicado: (1996)

Matrix Metalloproteinase-9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in Sepsis after Major Abdominal Surgery
por: Bojic, Suzana, et al.
Publicado: (2018)

Matrix Metalloproteinase-1 and Matrix Metalloproteinase-9 in the Aqueous Humor of Diabetic Macular Edema Patients
por: Kwon, Jin-woo, et al.
Publicado: (2016)

Matrix metalloproteinases in arthritic disease
por: Murphy, Gillian, et al.
Publicado: (2002)

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study
por: Peeters, S. A., et al.
Publicado: (2017)

Enhancement of fibrinogen-triggered pro-coagulant activation of monocytes in vitro by matrix metalloproteinase-9
por: Kaneider, Nicole C, et al.
Publicado: (2010)

Membrane Type 1 Matrix Metalloproteinase Regulates Monocyte Migration and Collagen Destruction in Tuberculosis
por: Sathyamoorthy, Tarangini, et al.
Publicado: (2015)

Amphiregulin Regulates Phagocytosis-Induced Cell Death in Monocytes via EGFR and Matrix Metalloproteinases
por: Platen, Christopher, et al.
Publicado: (2018)

Levels of plasma matrix metalloproteinases (MMP-2 and MMP-9) in response to INTEGRA(®) dermal regeneration template implantation
por: Nessler, MichałBohdan, et al.
Publicado: (2014)

Matrix metalloproteinases are possible targets in monocrotaline-induced pulmonary hypertension: investigation of anti-remodeling effects of alagebrium and everolimus
por: Atlı, Özlem, et al.
Publicado: (2017)

Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients
por: Trentini, Alessandro, et al.
Publicado: (2016)

Matrix metalloproteinases in subjects with type 1 diabetes
por: Gharagozlian, Sedegheh, et al.
Publicado: (2009)

Evaluation of monocyte to high-density lipoprotein ratio, lymphocytes, monocytes, and platelets in psoriasis()()
por: Aktaş Karabay, Ezgi, et al.
Publicado: (2020)

Inhibition of matrix metalloproteinase-9 secretion by dimethyl sulfoxide and cyclic adenosine monophosphate in human monocytes
por: Denner, Darcy R, et al.
Publicado: (2021)

Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study
por: Milčić, Danijela, et al.
Publicado: (2017)

Correlation between serum matrix metalloproteinase and myocardial fibrosis in heart failure patients with reduced ejection fraction: A retrospective analysis
por: Çelik, Ömer, et al.
Publicado: (2020)

Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14
por: Buache, Emilie, et al.
Publicado: (2014)

Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in the hair cycle
por: HOU, CHUN, et al.
Publicado: (2016)

Effect of advanced glycation end products, extracellular matrix metalloproteinase inducer and matrix metalloproteinases on type-I collagen metabolism
por: LI, WANG, et al.
Publicado: (2016)

Interferon-Gamma Increases the Ratio of Matrix Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 in Peripheral Monocytes from Patients with Coronary Artery Disease
por: Springall, Rashidi, et al.
Publicado: (2013)

Matrix metalloproteinases and epileptogenesis
por: Ikonomidou, Chrysanthy
Publicado: (2014)

Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022)

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke
por: Manso, Helena, et al.
Publicado: (2010)

SKIP Downregulation Increases TGF-β1-Induced Matrix Metalloproteinase-9 Production in Transformed Keratinocytes
por: Kocić, Jelena, et al.
Publicado: (2012)

Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease
por: Medeiros, Nayara I., et al.
Publicado: (2017)

Ureaplasma isolates stimulate pro-inflammatory CC chemokines and matrix metalloproteinase-9 in neonatal and adult monocytes
por: Glaser, Kirsten, et al.
Publicado: (2018)

Urinary Matrix Metalloproteinase-9 and Nephrin in Idiopathic Membranous Nephropathy: A Cross-Sectional Study
por: Gilbert, Akankwasa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_83c3pldu36se5tlbq4ndgmdkib